BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20171029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171231
DTEND;VALUE=DATE:20180203
DTSTAMP:20260729T143533
CREATED:20171231T112321Z
LAST-MODIFIED:20171231T112321Z
UID:19562-1514678400-1517615999@ces.b2sg.org
SUMMARY:Assistant/ Associate/ Full Professor
DESCRIPTION:The Department of Cancer Biology at The University of Texas MD Anderson Cancer Center invites applicants for a full-time term tenure track academic appointment at the level of Assistant\, Associate\, or Full Professor. We seek exceptional scientists or physician scientists with demonstrated dedication to solving fundamental questions about the origin\, progression\, dissemination\, and resistance to therapy of cancer as well as basic scientists working on fundamental processes relevant to cancer. The successful applicant will develop a hypothesis-driven basic and translational research program in the field of general biology\, cancer pathogenesis\, cancer biology\, or cancer genetics. Preference will be given to candidates committed to conduct mechanistic studies by employing a variety of approaches\, ranging from genomics\, mouse modeling\, and biochemistry to high-resolution in vivo imaging. A secondary appointment in an appropriate clinical or basic science department will be considered. Areas of interest include – but are not limited to – epigenetics\, cell fate determination\, structural biology\, tumor microenvironment and cell signaling. \nThe position offers enormous opportunities for professional growth and development. The successful candidate will join an exciting and active group of investigators\, including Ron DePinho\, Filippo Giancotti\, Jian Hu\, Raghu Kalluri\, Valerie LeBleu\, Randy Johnson\, Katharina Schlacher\, and among others. The joint faculty of the department include James P. Allison\, David Piwnica-Worms\, John Tainer and others. The faculty member will have access to the department’s substantial resources\, including cutting edge core facilities\, animal models\, and educational/training programs. A very generous start-up package is available for the Faculty member’s research program; furthermore\, it is anticipated that successful candidates will have the scientific caliber and accomplishments to compete successfully for a Recruitment Award from the Cancer Research and Prevention Institute of Texas (CPRIT) and The University of Texas Regents Funding. Refer to the Department of Cancer Biology Web page for additional information about the department and its programs.
URL:https://ces.b2sg.org/event/mdanderson-31dec17/
LOCATION:MD Anderson Cancer Center\, 1515 Holcombe Blvd\, Houston\, TX\, 77030\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/MDAnderson.jpg
END:VEVENT
END:VCALENDAR